Industry News
-
Novartis Stands By Its $12B Avidity Bet Despite a $1.9B Impairment on a Muscular Dystrophy Candidate
Oct 27 2026 -
FDA Draft Guidance Would Streamline Approvals of Individualized Gene-Editing Therapies
Oct 27 2026 -
Plowshare Therapies Advances an AAV Gene Therapy for Maple Syrup Urine Disease, with a Calf as Proof of Concept
Oct 27 2026 -
Researchers Identify Biomarkers That Predict Cytokine Release Syndrome Risk After CAR T-Cell Therapy
Oct 26 2026 -
Sanofi and ScionxBio Partner on Long-Acting mRNA Therapies
Oct 21 2026 -
FDA Approves GSK and Ionis’s Bepirovirsen (Hibsago), the First Antisense ‘Functional Cure’ for Hepatitis B
Oct 21 2026 -
Merck KGaA to Acquire Silence Therapeutics for $1.3B, Moving into RNAi
Oct 19 2026 -
A Faster Way to Screen AAV Purification: UV Light-Scattering High-Throughput Method
Oct 13 2026 -
Trispecific CAR T-Cell Therapy Shows Early Promise in Hard-to-Treat B-Cell Cancers
Oct 13 2026